Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130849281> ?p ?o ?g. }
- W2130849281 endingPage "359" @default.
- W2130849281 startingPage "350" @default.
- W2130849281 abstract "Summary The E‐, L‐ and P‐selectins are carbohydrate‐recognizing cell‐adhesion molecules mediating selective leucocyte recruitment in inflammation. The 3′‐sialyl‐ and 3′‐sulpho‐oligosaccharides of Lewis x (Le x ) and Lewis a (Le a ) series are bound by them, but for high‐avidity binding of P‐ and L‐selectins to the glycoprotein counter‐receptor known as P‐selectin glycoprotein ligand, PSGL‐1, there is a requirement for sulpho‐tyrosines neighbouring a sialyl‐Le x glycan. The two selectins can also bind 3‐ O ‐ or 6‐ O ‐sulphated galacto‐lipids (sulphatides). Here we compare some features of the interactions of P‐ and L‐selectins with a novel lipid‐linked sulpho‐tyrosine probe, and with the sulphatides and neoglycolipids of sialyl‐ and sulpho‐Le x /Le a fuco‐oligosaccharides. The sulpho‐tyrosine probe is bound by both selectins. There are close similarities in the interactions of the two selectins with sulpho‐tyrosine and the sulphatides; the binding is relatively resistant to chelation of calcium ions, in contrast to the absolute requirement of calcium ions with the long fuco‐oligosaccharides, including 6‐sulpho‐sialyl‐Le x . With both selectins, there is striking synergy in binding signals elicited by the two ligand types when presented as equimolar mixtures on a matrix. Thus, there are two operationally distinct binding sites on both L‐ and P‐selectin; and the binding sites for sulphate groups in the two ligand types are probably distinct. When sulpho‐tyrosine and sialyl‐Le x are presented on liposomes, a potent inhibitory activity is generated toward the binding of P‐selectin to HL60 cells, with 50% inhibitory concentration (IC 50 ) values in the nanomolar range. These features of the lipid‐linked ligand analogues, and the simple approach for their display on liposomes, may have applications in designs and screening of selectin inhibitors as anti‐inflammatory compounds." @default.
- W2130849281 created "2016-06-24" @default.
- W2130849281 creator A5028056978 @default.
- W2130849281 creator A5032218017 @default.
- W2130849281 creator A5033487077 @default.
- W2130849281 creator A5084811007 @default.
- W2130849281 creator A5087958783 @default.
- W2130849281 creator A5089106164 @default.
- W2130849281 date "2002-03-01" @default.
- W2130849281 modified "2023-10-18" @default.
- W2130849281 title "Synergistic interactions of the two classes of ligand, sialyl-Lewis<sup>ax</sup>fuco-oligosaccharides and short sulpho-motifs, with the P- and L-selectins: implications for therapeutic inhibitor designs" @default.
- W2130849281 cites W1544830465 @default.
- W2130849281 cites W1602883214 @default.
- W2130849281 cites W1967959407 @default.
- W2130849281 cites W1968104539 @default.
- W2130849281 cites W1975630826 @default.
- W2130849281 cites W1980365019 @default.
- W2130849281 cites W1985572665 @default.
- W2130849281 cites W1987396883 @default.
- W2130849281 cites W1989131965 @default.
- W2130849281 cites W1994296349 @default.
- W2130849281 cites W1995579116 @default.
- W2130849281 cites W1997196395 @default.
- W2130849281 cites W1997775470 @default.
- W2130849281 cites W1999438227 @default.
- W2130849281 cites W2003415902 @default.
- W2130849281 cites W2004113867 @default.
- W2130849281 cites W2004432012 @default.
- W2130849281 cites W2007674354 @default.
- W2130849281 cites W2010080800 @default.
- W2130849281 cites W2011444759 @default.
- W2130849281 cites W2014213146 @default.
- W2130849281 cites W2016573683 @default.
- W2130849281 cites W2019781203 @default.
- W2130849281 cites W2022735002 @default.
- W2130849281 cites W2022797612 @default.
- W2130849281 cites W2023693583 @default.
- W2130849281 cites W2032616796 @default.
- W2130849281 cites W2041310039 @default.
- W2130849281 cites W2041953295 @default.
- W2130849281 cites W2041963881 @default.
- W2130849281 cites W2043635109 @default.
- W2130849281 cites W2043790697 @default.
- W2130849281 cites W2060512529 @default.
- W2130849281 cites W2063789304 @default.
- W2130849281 cites W2066175542 @default.
- W2130849281 cites W2074068472 @default.
- W2130849281 cites W2076424203 @default.
- W2130849281 cites W2080700473 @default.
- W2130849281 cites W2096898060 @default.
- W2130849281 cites W2099980678 @default.
- W2130849281 cites W2102440339 @default.
- W2130849281 cites W2103013259 @default.
- W2130849281 cites W2108650504 @default.
- W2130849281 cites W2112998064 @default.
- W2130849281 cites W2122229718 @default.
- W2130849281 cites W2134742523 @default.
- W2130849281 cites W2140449516 @default.
- W2130849281 cites W2146976502 @default.
- W2130849281 cites W2148918528 @default.
- W2130849281 cites W2292418496 @default.
- W2130849281 cites W2994044151 @default.
- W2130849281 cites W4246991801 @default.
- W2130849281 doi "https://doi.org/10.1046/j.1365-2567.2002.01369.x" @default.
- W2130849281 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1782666" @default.
- W2130849281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11918697" @default.
- W2130849281 hasPublicationYear "2002" @default.
- W2130849281 type Work @default.
- W2130849281 sameAs 2130849281 @default.
- W2130849281 citedByCount "34" @default.
- W2130849281 countsByYear W21308492812012 @default.
- W2130849281 countsByYear W21308492812013 @default.
- W2130849281 countsByYear W21308492812014 @default.
- W2130849281 countsByYear W21308492812015 @default.
- W2130849281 countsByYear W21308492812018 @default.
- W2130849281 countsByYear W21308492812019 @default.
- W2130849281 countsByYear W21308492812021 @default.
- W2130849281 countsByYear W21308492812022 @default.
- W2130849281 countsByYear W21308492812023 @default.
- W2130849281 crossrefType "journal-article" @default.
- W2130849281 hasAuthorship W2130849281A5028056978 @default.
- W2130849281 hasAuthorship W2130849281A5032218017 @default.
- W2130849281 hasAuthorship W2130849281A5033487077 @default.
- W2130849281 hasAuthorship W2130849281A5084811007 @default.
- W2130849281 hasAuthorship W2130849281A5087958783 @default.
- W2130849281 hasAuthorship W2130849281A5089106164 @default.
- W2130849281 hasBestOaLocation W21308492811 @default.
- W2130849281 hasConcept C108625454 @default.
- W2130849281 hasConcept C116569031 @default.
- W2130849281 hasConcept C155619193 @default.
- W2130849281 hasConcept C170493617 @default.
- W2130849281 hasConcept C178790620 @default.
- W2130849281 hasConcept C185592680 @default.
- W2130849281 hasConcept C206212055 @default.
- W2130849281 hasConcept C22222904 @default.
- W2130849281 hasConcept C2776165026 @default.
- W2130849281 hasConcept C2777117008 @default.
- W2130849281 hasConcept C55493867 @default.